Martin Gerstel

From Wikipedia, the free encyclopedia

Martin Gerstel was born on June 26, 1941. He is a businessman who was the CEO and co-chairman of Alza Corp. He is the chairman of Compugen (Israeli company), Evogene, Keddem Bioscience, Mada Ltd., the co-founder and co-chairman of Itamar Medical, and serves as a director of Yissum Research Development Company of Hebrew University Ltd., Yeda Ltd. and the Foundation for the U.S. National Medals of Science and Technology. He is a member of the Board of Governors and the Executive Committee of the Weizmann Institute of Science and the Board of Governors of The Hebrew University of Jerusalem, and is an advisor to the Burrill Life Science Funds and the board of the Israel-U.S. Binational Industrial Research and Development Foundation (“BIRD”).^[1] Gerstel holds a B.S. from Yale University and an MBA from Stanford University.

Gerstel is married to Shoshna Gerstel (Weksler) an is the father of Gil Gerstel.

References

↑ "Compugen Ltd (CGEN) – 6-K – 7/2/2003". EDGAR Online. 2 June 2003. Retrieved 15 December 2011.

External links

"Martin Gerstel's back in business, this time in Israel" – Israel21c
Martin S. Gerstel Profile – Forbes.com
Evogene official site
Itamar Medical official site
Yissum official site
Yeda official site

Persondata
Name	Gerstel, Martin
Alternative names
Short description	Businessperson
Date of birth	June 26, 1941
Place of birth
Date of death
Place of death

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.